Evidence map›Paper›PMID 39918317›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Multi-task AI models in dermatology: Overcoming critical clinical translation challenges for enhanced skin lesion diagnosis.

Deval Mehta, Clare Primiero, Brigid Betz-Stablein, Toan D Nguyen, Yaniv Gal, Adrian Bowling, Martin Haskett, Maithili Sashindranath, Paul Bonnington, Victoria Mar and 2 more

Abstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Deval MehtaAIM for Health Lab, Faculty of IT, Monash University, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0002-6907-7589
Clare PrimieroDermatology Research Centre, Frazer Institute, the University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0002-2944-0013
Brigid Betz-StableinDermatology Research Centre, Frazer Institute, the University of Queensland, Brisbane, Queensland, Australia.ORCID https://orcid.org/0000-0003-3876-501X
Toan D NguyenE-Research Center, Monash University, Melbourne, Victoria, Australia.
Yaniv GalMolemap Pty. Ltd., Melbourne, Victoria, Australia.
Adrian BowlingMolemap Pty. Ltd., Melbourne, Victoria, Australia.
Martin HaskettMolemap Pty. Ltd., Melbourne, Victoria, Australia.
Maithili SashindranathAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Paul BonningtonThe University of Queensland, Brisbane, Queensland, Australia.
Victoria MarSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
H Peter SoyerDermatology Research Centre, Frazer Institute, the University of Queensland, Brisbane, Queensland, Australia.
Zongyuan GeAIM for Health Lab, Faculty of IT, Monash University, Melbourne, Victoria, Australia.

Funding

National Health and Medical Research Council (NHMRC) Grant: Skin Imaging and Precision Diagnosis 2006551National Health and Medical Research Council (NHMRC) Synergy Grant: Roadmap Options for Melanoma Screening in Australia 2009923
6 · The paper itself

Abstract

backgroundThe surge in AI models for diagnosing skin lesions through image analysis is notable, yet their clinical implementation faces challenges. Common limitations include an over reliance on dermoscopy, lack of real-world applicability when only binary output (e.g. benign/malignant) is offered and low accuracy when faced with rare skin conditions.

objectivesTo address these common constraints associated with limited diagnostic output, and applicability to real-world settings.

methodsWe developed an All-In-One Hierarchical-Out of Distribution-Clinical Triage (HOT) AI model for skin lesion analysis. Trained on a large dataset of ~208,000 lesion images, our HOT AI model generates three outputs: a hierarchical three-level prediction, an alert for out-of-distribution (OOD) images and a recommendation for dermoscopy to improve diagnostic prediction.

resultsOur hierarchical prediction output provides a binary level 1 prediction (benign/malignant), Level 2 prediction of eight possible categories (e.g. melanocytic and keratinocytic) and a more definitive Level 3 prediction from 44 lesion categories. The model produced high sensitivity for Level 1 prediction (88.14% CI: 87.42-88.51); however, significantly lower for Level 3 prediction (63.90%, CI: 62.27-65.61). By relying on all three prediction levels for consensus, Level 1 false-positives were reduced by 20-25%, and false-negatives were decreased by 11-13% of cases. OOD detection was benchmarked against previous landmark models and outperformed comparative models. Lastly, 44% of images were recommended for dermoscopy, and with additional image input, Level 3 sensitivity increased from 48.13% (CI:45.08-49.57) to 52.54% (CI:50.25-55.04).

conclusionsOur HOT-AI model attempts to address common challenges in existing models by combining three tasks in one model to increase accuracy and clinical utility. By providing a more nuanced prediction, and alert for OOD, the model output provides greater explainability of the AI decision process. Prospective clinical testing is required to measure how this additional output impacts user trust, and how the model performs in a real-world setting.

Indexed as

Artificial IntelligenceDermatologySkin DiseasesSkin NeoplasmsDermoscopyHumans

Identifiers

PMID39918317
PMCPMC12645183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.